Patents by Inventor Neil Mortimer

Neil Mortimer has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Dispersible Tablet Formulations Comprising Dolutegravir
    Publication number: 20230285307
    Abstract: The present invention relates to formulations comprising dolutegravir or a pharmaceutically acceptable salt thereof, processes for making such formulations, and the use of such formulations in the treatment of HIV infection, in particular in the treatment of HIV infection in pediatric patients.
    Type: Application
    Filed: June 23, 2021
    Publication date: September 14, 2023
    Applicant: ViiV Healthcare Company
    Inventors: Ian Paul CONN, Mark Robert DAVIES, Joanne HEAFIELD, Michael HOLTON, Neil MORTIMER
  • Process for preparing solid dosage forms of very low-dose drugs
    Publication number: 20030129246
    Abstract: A drug formulation process which comprises admixing carrier particles with a solution of drug in water in a quantity of 1-3% by weight of solution to total mix and a method of treatment and/or prophylaxis of dementia, which method comprises administering to the patient [R-(Z)]-&agr;-(methoxyimino)-&agr;-(1-azabicyclo [2.2.2]oct-3-yl)acetonitrile monohydrochloride at a daily dose below 0.01 mg/kg and pharmaceutical compositions used therein.
    Type: Application
    Filed: February 26, 2003
    Publication date: July 10, 2003
    Applicant: SmithKline Beecham p.l.c.
    Inventors: James Albert Napper, Karen Triona O'Brien, Sultan James Manek, Rajinder Kumar, Julia Mary Loudon, Michael Sydney George Clark, Neil Mortimer
  • Process for preparing solid dosage forms of very low-dose drugs
    Publication number: 20020150618
    Abstract: A drug formulation process which comprises admixing carrier particles with a solution of drug in water in a quantity of 1-3% by weight of solution to total mix and a method of treatment and/or prophylaxis of dementia, which method comprises administering to the patient [R-(Z)]-&agr;-(methoxyimino)-&agr;-(1-azabicyclo [2.2.2]oct-3-yl)acetonitrile monohydrochloride at a daily dose below 0.01 mg/kg and pharmaceutical compositions used therein.
    Type: Application
    Filed: June 10, 2002
    Publication date: October 17, 2002
    Applicant: SmithKline Beecham p.l.c.
    Inventors: James Albert Napper, Karen Triona O'Brien, Sultan James Manek, Rajinder Kumar, Julia Mary Loudon, Michael Sydney George Clark, Neil Mortimer
  • Process for preparing solid dosage forms of very low-dose drugs
    Publication number: 20010018074
    Abstract: A drug formulation process which comprises admixing carrier particles with a solution of drug in water in a quantity of 1-3% by weight of solution to total mix and a method of treatment and/or prophylaxis of dementia, which method comprises administering to the patient [R-(Z)]-&agr;-(methoxyimino)-&agr;-(1-azabicyclo [2.2.2]oct-3-yl)acetonitrile monohydrochloride at a daily dose below 0.01 mg/kg and pharmaceutical compositions used therein.
    Type: Application
    Filed: January 12, 2001
    Publication date: August 30, 2001
    Applicant: SmithKline Beecham p.l.c.
    Inventors: James Albert Napper, Karen Triona O'Brien, Sultan James Manek, Rajinder Kumar, Julia Mary Loudon, Michael Sydney George Clark, Neil Mortimer